217 related articles for article (PubMed ID: 22139536)
1. MR molecular imaging of prostate cancer with a peptide-targeted contrast agent in a mouse orthotopic prostate cancer model.
Tan M; Burden-Gulley SM; Li W; Wu X; Lindner D; Brady-Kalnay SM; Gulani V; Lu ZR
Pharm Res; 2012 Apr; 29(4):953-60. PubMed ID: 22139536
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of a targeted nanoglobular dual-modal imaging agent for MR imaging and image-guided surgery of prostate cancer.
Tan M; Ye Z; Lindner D; Brady-Kalnay SM; Lu ZR
Pharm Res; 2014 Jun; 31(6):1469-76. PubMed ID: 23471641
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of a peptide targeted small molecular Gd-DOTA monoamide conjugate for MR molecular imaging of prostate cancer.
Wu X; Burden-Gulley SM; Yu GP; Tan M; Lindner D; Brady-Kalnay SM; Lu ZR
Bioconjug Chem; 2012 Aug; 23(8):1548-56. PubMed ID: 22812444
[TBL] [Abstract][Full Text] [Related]
4. MR molecular imaging of prostate cancer with a small molecular CLT1 peptide targeted contrast agent.
Wu X; Lindner D; Yu GP; Brady-Kalnay S; Lu ZR
J Vis Exp; 2013 Sep; (79):. PubMed ID: 24056726
[TBL] [Abstract][Full Text] [Related]
5. Peptide-targeted Nanoglobular Gd-DOTA monoamide conjugates for magnetic resonance cancer molecular imaging.
Tan M; Wu X; Jeong EK; Chen Q; Lu ZR
Biomacromolecules; 2010 Mar; 11(3):754-61. PubMed ID: 20131758
[TBL] [Abstract][Full Text] [Related]
6. A peptide targeted contrast agent specific to fibrin-fibronectin complexes for cancer molecular imaging with MRI.
Ye F; Wu X; Jeong EK; Jia Z; Yang T; Parker D; Lu ZR
Bioconjug Chem; 2008 Dec; 19(12):2300-3. PubMed ID: 19053180
[TBL] [Abstract][Full Text] [Related]
7. Molecular MRI of liver fibrosis by a peptide-targeted contrast agent in an experimental mouse model.
Chow AM; Tan M; Gao DS; Fan SJ; Cheung JS; Man K; Lu ZR; Wu EX
Invest Radiol; 2013 Jan; 48(1):46-54. PubMed ID: 23192162
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of globular Gd-DOTA-monoamide conjugates with precisely controlled nanosizes for magnetic resonance angiography.
Kaneshiro TL; Jeong EK; Morrell G; Parker DL; Lu ZR
Biomacromolecules; 2008 Oct; 9(10):2742-8. PubMed ID: 18771313
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Assessment of Peptide Gd-DOTA Conjugates Targeting Extradomain B Fibronectin for Magnetic Resonance Molecular Imaging of Prostate Cancer.
Li Y; Han Z; Roelle S; DeSanto A; Sabatelle R; Schur R; Lu ZR
Mol Pharm; 2017 Nov; 14(11):3906-3915. PubMed ID: 28976766
[TBL] [Abstract][Full Text] [Related]
10. An effective targeted nanoglobular manganese(II) chelate conjugate for magnetic resonance molecular imaging of tumor extracellular matrix.
Tan M; Wu X; Jeong EK; Chen Q; Parker DL; Lu ZR
Mol Pharm; 2010 Aug; 7(4):936-43. PubMed ID: 20481565
[TBL] [Abstract][Full Text] [Related]
11. Targeted Contrast Agents for Magnetic Resonance Molecular Imaging of Cancer.
Lu ZR; Laney V; Li Y
Acc Chem Res; 2022 Oct; 55(19):2833-2847. PubMed ID: 36121350
[TBL] [Abstract][Full Text] [Related]
12. Peptide targeted high-resolution molecular imaging of prostate cancer with MRI.
Wu X; Yu G; Lindner D; Brady-Kalnay SM; Zhang Q; Lu ZR
Am J Nucl Med Mol Imaging; 2014; 4(6):525-36. PubMed ID: 25250202
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of CLT1-(Gd-DTPA) for Cancer MR Molecular Imaging in a Mouse Breast Cancer Model.
Ye F; Jeong EK; Parker D; Lu ZR
Bo Pu Xue Za Zhi; 2011; 2(5):325-330. PubMed ID: 24453461
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of nanoglobular macrocyclic Mn(II) chelate conjugates as non-gadolinium(III) MRI contrast agents.
Tan M; Ye Z; Jeong EK; Wu X; Parker DL; Lu ZR
Bioconjug Chem; 2011 May; 22(5):931-7. PubMed ID: 21473650
[TBL] [Abstract][Full Text] [Related]
15. Magnetic-optical dual-modality imaging monitoring chemotherapy efficacy of pancreatic ductal adenocarcinoma with a low-dose fibronectin-targeting Gd-based contrast agent.
Zhang W; Liang X; Zhang X; Tong W; Shi G; Guo H; Jin Z; Tian J; Du Y; Xue H
Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):1841-1855. PubMed ID: 38372766
[TBL] [Abstract][Full Text] [Related]
16. An efficient MRI agent targeting extracellular markers in prostate adenocarcinoma.
Pagoto A; Tripepi M; Stefania R; Lanzardo S; Livio Longo D; Garello F; Porpiglia F; Manfredi M; Aime S; Terreno E
Magn Reson Med; 2019 Mar; 81(3):1935-1946. PubMed ID: 30257047
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
